Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.

Item

http://www.wikidata.org/entity/Q35675837

Q35675837

about

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.

Item

http://www.wikidata.org/entity/Q35675837

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@ast

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@en

type

Item

label

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@ast

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@en

prefLabel

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@ast

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@en

P1476

Lipopolysaccharide-Induced CXC ...... atients with Multiple Myeloma.

@en

P2093

Ken Ohmachi

http://www.w3.org/2001/XMLSchema#string

Kenshi Suzuki

http://www.w3.org/2001/XMLSchema#string

Masahiro Abe

http://www.w3.org/2001/XMLSchema#string

Masahiro Kizaki

http://www.w3.org/2001/XMLSchema#string

Masaki Ri

http://www.w3.org/2001/XMLSchema#string

Masato Mitsuhashi

http://www.w3.org/2001/XMLSchema#string

Mizuki Chosa

http://www.w3.org/2001/XMLSchema#string

Morihiko Sagawa

http://www.w3.org/2001/XMLSchema#string

Shingen Nakamura

http://www.w3.org/2001/XMLSchema#string

Shinsuke Iida

http://www.w3.org/2001/XMLSchema#string

P2860

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R

Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy

International uniform response criteria for multiple myeloma.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

P304

e0128662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0128662

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281358580

http://www.w3.org/2001/XMLSchema#string

P698

26115406

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

biomarker

P932

4482752

http://www.w3.org/2001/XMLSchema#string

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.

about

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932